NeuEsse, Inc.
NeuEsse Inc. is dedicated to advancing skin health through innovative plant-based technologies. Their mission is to provide effective solutions for skin repair, addressing challenges such as severe burns, wounds, and trauma. Their flagship product, OmegaSkin™, is a human skin substitute made from soy protein, designed to enhance healing outcomes with minimal scarring. NeuEsse aims to meet the unmet needs in wound treatment, offering products that are sustainable, vegan-friendly, and require no special handling.
Industries
N/A
Nr. of Employees
small (1-50)
NeuEsse, Inc.
322 North Shore Drive, Building 1B, Suite 200, Pittsburgh, PA 15212
Products
Electrospun plant-protein skin substitute (sheet format)
Sterilized, pre-manufactured nanofibrous sheets derived from soy protein isolate intended as an off-the-shelf acellular scaffold for coverage of acute and chronic full-thickness wounds; designed for storage without refrigeration and available in standard or custom sizes.
Sprayable plant-protein skin substitute (liquid formulation)
A liquid formulation of the soy-protein scaffold intended for touch-free, uniform coverage of wounds and hard-to-reach anatomical areas, compatible with a handheld applicator and supplied in sterile, single-use containers.
Handheld electrospinning/electroblowing applicator (portable delivery device)
Battery-operated portable applicator designed to deposit electrospun or sprayable scaffold materials in a no-touch manner; concepts include single-chamber and multi-chamber versions to deliver different therapeutics at the point of injury.
Porous gradient electrospun scaffold
An electrospun soy-protein scaffold engineered with a gradient porous structure to increase pore diameter for improved cellular infiltration and to modulate macrophage biology toward tissue remodeling.
Electrospun plant-protein skin substitute (sheet format)
Sterilized, pre-manufactured nanofibrous sheets derived from soy protein isolate intended as an off-the-shelf acellular scaffold for coverage of acute and chronic full-thickness wounds; designed for storage without refrigeration and available in standard or custom sizes.
Sprayable plant-protein skin substitute (liquid formulation)
A liquid formulation of the soy-protein scaffold intended for touch-free, uniform coverage of wounds and hard-to-reach anatomical areas, compatible with a handheld applicator and supplied in sterile, single-use containers.
Handheld electrospinning/electroblowing applicator (portable delivery device)
Battery-operated portable applicator designed to deposit electrospun or sprayable scaffold materials in a no-touch manner; concepts include single-chamber and multi-chamber versions to deliver different therapeutics at the point of injury.
Porous gradient electrospun scaffold
An electrospun soy-protein scaffold engineered with a gradient porous structure to increase pore diameter for improved cellular infiltration and to modulate macrophage biology toward tissue remodeling.
Expertise Areas
- Wound care product development
- Biomaterials and scaffold engineering
- Electrospinning and nanofiber fabrication
- Preclinical wound healing studies (rodent and porcine models)
Key Technologies
- Electrospinning
- Nanofibrous scaffold fabrication
- Soy protein isolate biomaterials
- Porous gradient scaffold design
News & Updates
NeuEsse will be attending the virtual BIONNALE b2 matchmaking event, a major networking event for life sciences and healthcare industries in Berlin.
A video presentation detailing how NeuEsse Inc. products are created from soybeans and the backstory of their creation.
NeuEsse's efforts in getting FDA approval and promoting their innovative products at the Emerging Medtech Summit.
NeuEsse will be attending the virtual BIONNALE b2 matchmaking event, a major networking event for life sciences and healthcare industries in Berlin.
A video presentation detailing how NeuEsse Inc. products are created from soybeans and the backstory of their creation.
NeuEsse's efforts in getting FDA approval and promoting their innovative products at the Emerging Medtech Summit.